Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,205 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by altodor, 01-10-2011, 11:17 AM
|
0 responses
1,086 views
0 reactions
|
Last Post
by altodor
01-10-2011, 11:17 AM
|
||
|
Started by teju, 01-07-2011, 11:48 PM
|
0 responses
1,376 views
0 reactions
|
Last Post
by teju
01-07-2011, 11:48 PM
|
||
|
Started by Vladimir_petit, 01-07-2011, 04:08 AM
|
0 responses
1,031 views
0 reactions
|
Last Post
|
||
|
Started by ghernand67, 12-30-2010, 08:53 AM
|
0 responses
1,675 views
0 reactions
|
Last Post
by ghernand67
12-30-2010, 08:53 AM
|
||
|
Started by read'me, 12-30-2010, 03:43 AM
|
0 responses
1,029 views
0 reactions
|
Last Post
by read'me
12-30-2010, 03:43 AM
|
||
|
Started by Pedro, 12-30-2010, 02:48 AM
|
0 responses
1,044 views
0 reactions
|
Last Post
by Pedro
12-30-2010, 02:48 AM
|
||
|
Started by becks, 12-28-2010, 05:25 AM
|
0 responses
1,508 views
0 reactions
|
Last Post
by becks
12-28-2010, 05:25 AM
|
||
|
Started by cpnine, 12-27-2010, 12:30 AM
|
0 responses
1,167 views
0 reactions
|
Last Post
by cpnine
12-27-2010, 12:30 AM
|
||
|
Started by aquila, 12-21-2010, 01:55 AM
|
0 responses
1,141 views
0 reactions
|
Last Post
by aquila
12-21-2010, 01:55 AM
|
||
|
Started by kweitemier, 12-20-2010, 04:07 PM
|
0 responses
2,549 views
0 reactions
|
Last Post
by kweitemier
12-20-2010, 04:07 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:35 AM
|
0 responses
7 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:35 AM
|
||
|
Started by SEQadmin2, 08-06-2026, 07:41 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
08-06-2026, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
45 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|